临床试验/DRKS00020117

DRKS00020117已完成不适用

Clinical outcomes in non-muscle invasive bladder cancer: A global multisite chart review study - MSD_NMBIC Chart review

Merck Sharp & Dohme Corp.0 个研究点目标入组 129 人开始时间: 2019年12月19日最近更新: 2024年8月19日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Merck Sharp & Dohme Corp.
入组人数: 129

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Observational

入排标准

年龄范围: 18 Years 至 one（—）
性别: All

入选标准

•histologically-confirmed diagnosis of high risk non-muscle-invasive (T1 [any grade], high grade Ta and / or carcinoma in situ [CIS]) transitional cell carcinoma of the bladder (mixed histology tumors allowed if transitional cell histology is predominant histology)

排除标准

•Muscle-invasive, locally advanced nonresectable, or metastatic urothelialcarcinoma (i.e., T2, T3, T4, and / or stage IV) at index date

研究者

发起方

Merck Sharp & Dohme Corp.

相似试验

RCT study of bladder instillation therapy in patients with refractory interstitial cystitis.

JPRN-UMIN000026714Department of Urology, Mitsui Memorial Hospital20

Response evaluation of muscle-invasive bladder cancer treated with radiotherapy and chemotherapy with Cisplatin or Gemcitabine

IRCT2017040332913N2Vice-Chancellor for Research of Iran University of Medical Sciences72

进行中（未招募）

Standard number and dose intravesical instillation therapy with BCG versus Reduced number and standard dose intravesical instillation therapy with BCG in patients with high grade non-muscle invasive urinary bladder carcinoma.

EUCTR2010-019181-91-FREAU Foundation for Urological Research824

进行中（未招募）

Treatment of High Grade Non-Muscle Invasive Urothelial Carcinoma of the Bladder by Standard Number and Dose of Intravesical BCG Instillations Versus Reduced Number of Intravesical Instillations with Standard Dose of BCG.bladderurothelial carcinomaC67Malignant neoplasm of bladder

DRKS00005651European Association of Urology359

进行中（未招募）

Standard number and dose intravesical instillation therapy with BCG versus Reduced number and standard dose intravesical instillation therapy with BCG in patients with high grade non-muscle invasive urinary bladder carcinoma.on muscle invasive bladder cancer after transurethral resection of the Bladder Tumor (TURT).MedDRA version: 20.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)

EUCTR2010-019181-91-BEEAU Foundation for Urological Research824